Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index contracted 6.7% to $853.8 million, and operating profits declined 6.1% to $259.2 million. Adjusted operating margins improved 30 basis points to 30.4% of sales. Biohit’s second-quarter sales declined 5% to €8.7 million ($11.9 million = €0.73 = $1), while operating income plunged 38% to €0.2 million ($0.3 […]
London, England 9/22/09, London, England 10/6/09—Millbrook Scientific Instruments has placed its subsidiary that manufactures the MiniSIMS (secondary ion MS) system into administration in order to conserve cash.
Cambridge, MA 9/16/09—Helicos Biosciences has raised approximately $9.4 million through a private placement of common stock and warrants. Purchasers include four existing investors, as well Ron Lowy, Helicos’s CEO, a new investor. In early September, the company announced it is considering strategic alternatives (see IBO 9/15/09).
Washington, DC 10/5/09—Sequenom has announced in a filing with the SEC that the US Attorneys Office, FBI and the NASDAQ have each met with the company regarding the results of its independent investigation into the development of a prenatal test for Down syndrome (see IBO 9/30/09). The investigation resulted in the firing of two company […]
New Dehli, India 10/2/09—GE Healthcare has announced that its joint venture with Wipro will take over its Indian and South Asian businesses, including GE Healthcare Life Sciences. The joint venture, in which GE Healthcare holds a 51% stake, currently distributes 85% of GE Medical Systems India’s products. The transaction will add 1,200 GE employees to […]
West Chester, PA 10/8/09; West Chester, PA 10/2/09—VWR International has agreed to purchase lab distributor OneMed Lab from health care products distributor OneMed Group for an undisclosed amount. OneMed Lab distributes lab equipment, chemicals and consumables in Finland, Norway and Sweden and has annual revenues of $30 million. The transaction is subject to regulatory approval. […]
Palo Alto, CA 10/6/09—Varian stockholders have voted at a special meeting on October 5 to approve the merger agreement with Agilent Technologies. Agilent plans to acquire Varian for $52 per share, or approximately $1.5 billion (see IBO 7/31/09). Approximately 84% of the shares of Varian common stock outstanding as of August 15 voted to adopt […]
Darmstadt, Germany and Bangalore, India 10/13/09—Merck KGaA has acquired Bangalore Genei (BGIP) through it wholly owned Indian subsidiary, Merck Specialities Private, from Sanmar Specialty Chemicals. The purchase price was not disclosed. BGIP specializes in the development, production, marketing and sale of products for proteomic and genomic research. BGIP has 100 employees and had fiscal 2009 […]
Although the latest economic forecasts for Asia, the US and Europe have increased growth estimates for next year, analytical instrument and laboratory product company executives are a bit less sanguine, but positive overall, according to the results of IBO’s latest Fall Business Climate Survey. Signs of recovery abound worldwide, though caution runs high due to […]
Compact flow cytometers operate like their larger counter parts, but with the added benefits of lower-cost and space-saving designs. As a result, individual researchers are able to use flow cytometers in their own labs. Compact flow cytometers typically have up to three integrated lasers, with some vendors offering upgrade options for four- or five-laser systems. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
